Download PDFPDF

Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Effects of vitamin E in mild-to-moderate asthmatics
    • Andrew W Fogarty, Lecturer in Respiratory Medicine
    • Other Contributors:
      • Philip Pearson, John Britton

    Dear Editor

    The aim of our study was to study ‘the effect of 6 weeks regular supplementation with vitamin E on the clinical control of asthma’ [1]. We thus used a combination of objective and subjective measures of asthma as our outcomes. The entry criteria were designed to be as inclusive as possible and to cover a population with mild to moderate asthma.

    However, as Currie et al highlight our study pop...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Effects of vitamin E in mild-to-moderate asthmatics

    Dear Editor

    Pearson et al [1] have failed to tease out any additional benefit of vitamin E supplementation in mild-to-moderate asthmatics. Before concluding that this is the case, it is relevant to highlight several points in their study.

    It is notable that the authors failed to measure any surrogate marker of inflammation such as exhaled nitric oxide, sputum eosinophils or airway hyperresponsiveness (AHR)...

    Show More
    Conflict of Interest:
    None declared.